Infertility |
|
|
Clinical Trial: Early Follicular Phase Downregulation and Androgen Priming in Short Protocol
This study is currently recruiting patients.
Verified by Rigshospitalet, Denmark September 2005
|
Purpose
The aim of the study is to evaluate early follicular phase downregulation and androgen priming using GnRH antagonist, aromatase inhibitor and hCG
| Condition | Intervention | Phase |
|---|---|---|
| Infertility Fertilization in vitro | Drug: Cetrotide, Arimidex, Pregnyl | Phase IV |
MedlinePlus related topics: Infertility
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Eligibility
Ages Eligible for Study: 20 Years - 39 Years, Genders Eligible for Study: Female
Criteria
Inclusion Criteria:
- Iindication for IVF/ICSI
- Age 20-39
- Regular menstrual cycle
- BMI 18-30 kg/m2
- Negative pregnancy test
Exclusion Criteria:
- Serious systemic desease
- PCOS
- Earlier "poor responder"
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00150501
Kristine Løssl, doctor 0045-35450464 kristine.loessl@rh.dk
Denmark, Copenhagen Ø
The Fertility Clinic 4071, Rigshospitalet, Copenhagen, Copenhagen Ø, 2100, Denmark; Recruiting
Kristine Løssl, doctor 0045-35450464 kristine.loessl@rh.dk
Anders N Andersen, chief anyboea@rh.dk
Kristine Løssl, doctor, Principal Investigator
Anders N Andersen, chief anyboea@rh.dk
Kristine Løssl, doctor, Principal Investigator
Study chairs or principal investigators
Anders N Andersen, dr.med, Study Director, Rigshospitalet, Denmark
Kristine Løssl, doctor, Principal Investigator, Rigshospitalet, Denmark
More Information
Study ID Numbers: priming 2005-05-20
Last Updated: September 7, 2005
Record first received: September 6, 2005
ClinicalTrials.gov Identifier: NCT00150501
Health Authority: Denmark: National Board of Health
ClinicalTrials.gov processed this record on 2005-09-13
Last Updated: September 7, 2005
Record first received: September 6, 2005
ClinicalTrials.gov Identifier: NCT00150501
Health Authority: Denmark: National Board of Health
ClinicalTrials.gov processed this record on 2005-09-13

Not Signed In -


